3B Blackbio Dx MD, chairman and AGM

3B Blackbio Dx board of directors

At the end of the quarter to Jun 2026, as the company filed it; changes since are in its announcements.Their trades in its shares

Chairperson and managing directorDhirendra Dubey
Company Secretary and Compliance OfficerNAVNEET KAUR

6 directors3 independent2 executive1 non-executive

Dhirendra Dubey · Chairperson and managing directorExecutive · joined Jul 1995 · 1 listed board
Nikhil Kuber DubeyExecutive · joined Aug 1993 · 1 listed board · 1 committee seat
Mithla DubeyNon-executive · joined Mar 2015 · 1 listed board · 1 committee seat
Harihar Prasad ThapakIndependent · joined Sep 2022 · reappointed Sep 2024 · 45 months as independent · 1 listed board · 1 as independent · 2 committee seats
Abdul Moin KhanIndependent · joined Sep 2017 · reappointed Sep 2022 · 105 months as independent · 1 listed board · 1 as independent
Vivek SaihgalIndependent · joined Aug 2025 · 10 months as independent · 1 listed board · 1 as independent

An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.

1 director who left

Rajesh Dubey, left 13 Jul 2025: Others

Committees and meetings

Who sits on each, and how often they met.Board meeting notices and outcomes

Board
- 29 May 20264 of 6 present2 independent · 34 days in between
- 24 Apr 20265 of 6 present3 independent · 76 days in between
- 6 Feb 20264 of 6 present1 independent
Audit Committee
Chair Abdul Moin Khan
Nikhil Kuber Dubey, Harihar Prasad Thapak
- 29 May 20263 of 3 present2 independent
- 24 Apr 20263 of 3 present2 independent · 76 days in between
- 6 Feb 20263 of 3 present2 independent
Nomination and remuneration committee
Chair Harihar Prasad Thapak
Mithla Dubey, Vivek Saihgal
- 24 Apr 20263 of 3 present2 independent
Stakeholders Relationship Committee
Chair Abdul Moin Khan
Mithla Dubey, Harihar Prasad Thapak
- 6 Feb 20263 of 3 present2 independent · 22 days in between
- 14 Jan 20263 of 3 present2 independent
Corporate Social Responsibility Committee
Chair Vivek Saihgal
Nikhil Kuber Dubey, Mithla Dubey
No meeting listed in the filing.

Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.

Statutory auditor

Named in the results for the quarter to Mar 2026.

M/s Baheti & Co.Peer-review certificate valid to Apr 2028

A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.

3B Blackbio Dx AGM and shareholder votes

Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.3B Blackbio Dx dividend history

Annual general meeting, 29 Sep 2026

11,122 shareholders on the register on 22 Sep 2026; present: 11 promoters and 42 others; votes counted by PRAVEEN KUMAR RAI / P.K.RAI & ASSOCIATES.The company's voting result (opens in a new tab)

To receive, consider and adopt the Audited Standalone Financial Statements of the Company for the financial year ended March 31, 2026 together with the Reports of the Board of Directors and Auditors thereon.MoreLess
Ordinary
100.00% for0.00% against
Against: promoters 0.00% · other public 0.00%
Turnout: all 66.83% · promoters 93.92% · other public 48.04%
To receive, consider and adopt the Audited Consolidated Financial Statements of the Company for the financial year ended March 31, 2026 together with the Reports of the Auditors thereon.
Ordinary
100.00% for0.00% against
Against: promoters 0.00% · other public 0.00%
Turnout: all 66.83% · promoters 93.92% · other public 48.04%
To declare dividend of 50% i.e., ?5/- Per equity share, for the financial year 2025-26.
Ordinary
100.00% for0.00% against
Against: promoters 0.00% · other public 0.00%
Turnout: all 66.83% · promoters 93.92% · other public 48.04%
To appoint a Director in place of Mrs. Mithla Dubey (DIN: 03597415) who retires by rotation and being eligible, offers herself for re-appointment.
SpecialPromoters have an interest in it
96.79% for3.21% against
Against: promoters 0.00% · other public 7.56%
Turnout: all 66.83% · promoters 93.92% · other public 48.04%
To Ratify Remuneration of Cost Auditors.
Ordinary
100.00% for0.00% against
Against: promoters 0.00% · other public 0.00%
Turnout: all 66.83% · promoters 93.92% · other public 48.04%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Dealings with its subsidiaries, promoters, directors and their firms, reported every half-year.Promoters and their stake

Half-year to Mar 2026: ₹11.6 Cr23 dealings
Half-year to Sep 2025: ₹11.1 Cr11 dealings
Half-year to Mar 2025: ₹6.5 Cr12 dealings
Half-year to Sep 2024: ₹5.5 Cr20 dealings
Half-year to Mar 2024: ₹32.3 Cr23 dealings
Half-year to Sep 2023: ₹24.3 Cr11 dealings

Between	Dealing
3B BLACKBIO DX LIMITED and TRUPCR Europe Limited, UK, Subsidiary Co.Holding-Subsidiary Company	Sale of goods or services	6.92	3.61	3.84
3B BLACKBIO DX LIMITED and TRUPCR Europe Limited, UK, Subsidiary Co.Holding-Subsidiary Company	Purchase of goods or services	0.87	0.00	0.87
3B BLACKBIO DX LIMITED and Nikhil Kuber DubeyWhole Time Director, CFO (KMP)	Any other transactionCommission	0.68	0.13	0.09
3B BLACKBIO DX LIMITED and Dhirendra DubeyChairman cum Managing Director (KMP)	Any other transactionCommission	0.68	0.49	0.07
TRUPCR Europe Limited, UK, Subsidiary Co. and Harminder SinghDirector of TRUPCR Europe Limited, UK, Subsidiary Co.	Any other transactionConsultancy Fees	0.43	0.00	0.08
3B BLACKBIO DX LIMITED and Mithla DubeyNon Executive Director	Dividend paid	0.42	0.00	0.00
3B BLACKBIO DX LIMITED and Dhirendra DubeyChairman cum Managing Director (KMP)	Dividend paid	0.29	0.00	0.00
3B BLACKBIO DX LIMITED and Nikhil Kuber DubeyWhole Time Director, CFO (KMP)	Remuneration	0.24	0.03	0.03
3B BLACKBIO DX LIMITED and Dhirendra DubeyChairman cum Managing Director (KMP)	Remuneration	0.24	0.03	0.03
TRUPCR Europe Limited, UK, Subsidiary Co. and Ragini Kumari DubeyDaughter of Mr. Nikhil Kuber Dubey	Any other transactionSalary from TRUPCR Europe Limited, UK, Subsidiary Co.	0.24	0.00	0.00
3B BLACKBIO DX LIMITED and Mithla DubeyNon Executive Director	Any other transactionRepayment of Deposit	0.18	0.18	0.00
3B BLACKBIO DX LIMITED and Nikhil Kuber DubeyWhole Time Director, CFO (KMP)	Dividend paid	0.14	0.00	0.00
3B BLACKBIO DX LIMITED and CORIS Bioconcept, SRL,Belgium, Subsidiary Co.Holding-Subsidiary Company	Purchase of goods or services	0.08	0.00	0.06
TRUPCR Europe Limited, UK, Subsidiary Co. and 3B BLACKBIO DX LIMITEDHolding-Subsidiary Company	Any other transactionInterest on Long term Loan	0.08	0.00	0.08
3B BLACKBIO DX LIMITED and Raghav DubeySon of Mr. Dhirendra Dubey	Any other transactionSalary	0.06	₹78,000	₹91,000
3B BLACKBIO DX LIMITED and Madhulika DubeyWife of Mr. Nikhil Kuber Dubey	Dividend paid	0.01	0.00	0.00
3B BLACKBIO DX LIMITED and Anamika DubeyWife of Mr. Dhirendra Dubey	Dividend paid	₹88,000	0.00	0.00
3B BLACKBIO DX LIMITED and Dhirendra DubeyChairman cum Managing Director (KMP)	Any other transactionSitting Fees	₹25,000	0.00	₹25,000
3B BLACKBIO DX LIMITED and Nikhil Kuber DubeyWhole Time Director, CFO (KMP)	Any other transactionSitting Fees	₹25,000	0.00	₹25,000
3B BLACKBIO DX LIMITED and Raghav DubeySon of Mr. Dhirendra Dubey	Dividend paid	₹9,000	0.00	0.00
3B BLACKBIO DX LIMITED and Ragini Kumari DubeyDaughter of Mr. Nikhil Kuber Dubey	Dividend paid	₹9,000	0.00	0.00
3B BLACKBIO DX LIMITED and Rishabh DubeySon of Mr. Dhirendra Dubey	Dividend paid	₹9,000	0.00	0.00
3B BLACKBIO DX LIMITED and Mithla DubeyNon Executive Director	Any other transactionSitting Fees	₹7,000	0.00	₹7,000

The 23 largest of 23 dealings in the half-year to Mar 2026, ₹ crore.

Investor complaints and compliance

Quarter by quarter.

Investor complaints received and resolved, the company's own count

Received
Resolved

Open at the quarter's end

None open at any quarter's end.

The board is made up as the listing rules require: Yes
The board has a regular chairperson: Yes
The company has a risk management committee: No
The chair is related to the managing director: Yes
The filing has a part on fines and penalties: No
The filing has a part on tax disputes: No
There was a cyber security incident in the quarter: No

The company's own answers in its filing.

3B Blackbio Dx board of directors

Committees and meetings

Board

Audit Committee

Nomination and remuneration committee

Stakeholders Relationship Committee

Corporate Social Responsibility Committee